Literature DB >> 31802581

Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: An example using real-world statin adherence data.

Ryan P Hickson1,2, Izabela E Annis1, Ley A Killeya-Jones1, Gang Fang1.   

Abstract

PURPOSE: The rationale for choosing a final group-based trajectory modeling (GBTM) specification and evaluations of patient adherence patterns within groups are often omitted in the GBTM medication adherence literature. We aimed to (1) reveal the complexity of GBTM and (2) assess model discrimination of patient medication adherence patterns.
METHODS: Medicare administrative claims were used to measure statin medication adherence as a continuous value in the 6 months before an acute myocardial infarction (AMI) hospitalization. Different GBTM specifications beyond default settings were constructed and compared with the Bayesian information criterion. Spaghetti plots were used to compare individual adherence patterns with group averages.
RESULTS: Overall, 113,296 prevalent statin users met eligibility criteria. Four adherence groups were identified: persistently adherent, moderately adherent, progressively nonadherent, and persistently nonadherent. Spaghetti plots showed the persistently adherent and persistently nonadherent groups had relatively homogeneous adherence patterns that matched predicted trajectories well. Spaghetti plots also showed that, while adherence patterns in the progressively nonadherent group were not as homogeneous, most patients in this group appeared to be discontinuing statin therapy pre-AMI.
CONCLUSIONS: Subjective decisions are necessary to identify a final trajectory model. Greater transparency and disclosure of these decisions in the medication adherence literature are needed. Individual patient adherence patterns from spaghetti plots provided additional diagnostic information about trajectory models beyond standard model-fit assessments to determine if group-average adherence estimates represent homogeneous patterns of medication adherence.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  group-based trajectory modeling; health behavior; medication adherence; methods; pharmacoepidemiology; statistical distributions

Mesh:

Substances:

Year:  2019        PMID: 31802581      PMCID: PMC7058496          DOI: 10.1002/pds.4917

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  9 in total

1.  Analyzing developmental trajectories of distinct but related behaviors: a group-based method.

Authors:  D S Nagin; R E Tremblay
Journal:  Psychol Methods       Date:  2001-03

2.  Group-based trajectory modeling: an overview.

Authors:  Daniel S Nagin
Journal:  Ann Nutr Metab       Date:  2014-11-18       Impact factor: 3.374

3.  Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.

Authors:  Jennifer L Hargrove; Virginia Pate; Carri H Casteel; Yvonne M Golightly; Laura R Loehr; Stephen W Marshall; Til Stürmer
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

4.  Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence.

Authors:  Jessica M Franklin; William H Shrank; Juliana Pakes; Gabriel Sanfélix-Gimeno; Olga S Matlin; Troyen A Brennan; Niteesh K Choudhry
Journal:  Med Care       Date:  2013-09       Impact factor: 2.983

5.  The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.

Authors:  Aaron N Winn; Stacie B Dusetzina
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-04-29       Impact factor: 2.890

6.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

7.  Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.

Authors:  Julián Librero; Gabriel Sanfélix-Gimeno; Salvador Peiró
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

8.  Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.

Authors:  Paul Dillon; Derek Stewart; Susan M Smith; Paul Gallagher; Gráinne Cousins
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

9.  Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang
Journal:  J Am Heart Assoc       Date:  2017-10-19       Impact factor: 5.501

  9 in total
  6 in total

1.  Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.

Authors:  Loreen Straub; Krista F Huybrechts; Sonia Hernández-Díaz; Yanmin Zhu; Seanna Vine; Rishi J Desai; Kathryn J Gray; Brian T Bateman
Journal:  Am J Epidemiol       Date:  2022-01-01       Impact factor: 5.363

2.  Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.

Authors:  Shelley A Jazowski; Lauren Wilson; Stacie B Dusetzina; S Yousuf Zafar; Leah L Zullig
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol.

Authors:  Caroline A Walsh; Sara Mucherino; Valentina Orlando; Kathleen E Bennett; Enrica Menditto; Caitriona Cahir
Journal:  HRB Open Res       Date:  2020-05-19

4.  Trajectory analyses in insurance medicine studies: Examples and key methodological aspects and pitfalls.

Authors:  Laura Serra; Kristin Farrants; Kristina Alexanderson; Mónica Ubalde; Tea Lallukka
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

5.  Delta T, a Useful Indicator for Pharmacy Dispensing Data to Monitor Medication Adherence.

Authors:  Pascal C Baumgartner; Bernard Vrijens; Samuel Allemann; Kurt E Hersberger; Isabelle Arnet
Journal:  Pharmaceutics       Date:  2022-01-02       Impact factor: 6.321

Review 6.  Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy.

Authors:  Mollie E Wood; Angela Lupattelli; Kristin Palmsten; Gretchen Bandoli; Caroline Hurault-Delarue; Christine Damase-Michel; Christina D Chambers; Hedvig M E Nordeng; Marleen M H J van Gelder
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.